Bristol-Myers Squibb: A Gem In A Period Of Macroeconomic Uncertainties [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Adene SanchezThe completion of the acquisitions of Celgene and MyoKardia has enabled Bristol-Myers Squibb (NYSE:BMYimmunology, oncology, and cardiovascular diseases, allowing it to carve out a niche in high-growth therapeutic areas. Rising inflation and geopolitical instability in the world are making the markets nervous and thus putting pressure on the price of BMY shares. Despite this, the company is successfully bringing new generation medicines to market, increasing the number of product candidates and reducing debt, creating a fantastic opportunity for investors to consider Bristol-Myers Squibb as a long-term asset.The outlook for BMY's product portfolio and its impact on the company's financial positionBristol-Myers Squibb's revenue came in at $11,887 million in Q2 2022, up 1.6% year-over-year. At the same time, the company's P/S ratio is 3.28x at the end of June 2022, which is significantly lower than the average for the healthcare sector, thus indicating that BMY is undervalue
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol-Myers Squibb: Market Pessimism Won't Last Forever [Seeking Alpha]Seeking Alpha
- 2 High-Yield Dividend Stocks to Buy and Hold for 10 Years [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/2/24 - Beat
BMY
Sec Filings
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BMY's page on the SEC website